Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 7 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CELL THERAPEUTICS INC | 15,000 | reported | 01 Jan 2004 | tx 1+15,000 |
| Aptose Biosciences Inc. | 3,333 | reported | 05 Feb 2024 | tx 18+838,333 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Feb 2024 | GRANT_AWARD | Aptose Biosciences Inc. | 3,333 | 0.00 USD | deriv |
| 19 Jan 2023 | GRANT_AWARD | Aptose Biosciences Inc. | 100,000 | 0.00 USD | deriv |
| 18 Jan 2022 | GRANT_AWARD | Aptose Biosciences Inc. | 50,000 | 0.00 USD | deriv |
| 16 Dec 2021 | PURCHASE | Aptose Biosciences Inc. | 20,000 | 1.40 USD | |
| 16 Dec 2021 | PURCHASE | Aptose Biosciences Inc. | 50,000 | 1.37 USD | |
| 16 Dec 2021 | PURCHASE | Aptose Biosciences Inc. | 30,000 | 1.38 USD | |
| 15 Dec 2021 | PURCHASE | Aptose Biosciences Inc. | 20,000 | 1.20 USD | first after silence |
| 15 Dec 2021 | PURCHASE | Aptose Biosciences Inc. | 100,000 | 1.18 USD | |
| 15 Dec 2021 | PURCHASE | Aptose Biosciences Inc. | 120,000 | 1.16 USD | |
| 15 Dec 2021 | PURCHASE | Aptose Biosciences Inc. | 30,000 | 1.19 USD | |
| 04 Jan 2021 | GRANT_AWARD | Aptose Biosciences Inc. | 50,000 | 0.00 USD | deriv |
| 11 Mar 2020 | GRANT_AWARD | Aptose Biosciences Inc. | 50,000 | 0.00 USD | deriv |
| 31 Jan 2020 | GRANT_AWARD | Aptose Biosciences Inc. | 135,000 | 0.00 USD | deriv |
| 19 Mar 2019 | SALE | Aptose Biosciences Inc. | 5,000 | 2.19 USD | |
| 19 Mar 2019 | SALE | Aptose Biosciences Inc. | 15,000 | 2.19 USD | |
| 02 Jan 2019 | GRANT_AWARD | Aptose Biosciences Inc. | 40,000 | 0.00 USD | deriv |
| 01 Jan 2004 | GRANT_AWARD | CELL THERAPEUTICS INC | 15,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 15 Dec 2021.